Companion Diagnostics

Tysabri gets boost from label change, new diagnostic

, Marc Iskowitz January 23, 2012

Biogen Idec and Elan, which market Tysabri for multiple sclerosis, won approval to add new safety information to the drug's label that could boost sales by helping doctors avoid a serious adverse event.
 

Pfizer's Xalkori and Abbott test show promise in personalized medicine, companion diagnostics

August 30, 2011

The FDA's approval of Pfizer's Xalkori (crizotinib) represents a leap forward for both personalized medicine and Pfizer's R&D turnaround, but its commercial success hinges on a pricey diagnostic array by Abbott's Vysis.
 

Video Exclusive

Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
 

MM&M Awards 2011 HIghlights

The Best MM&M Awards Ever!

MAHF Ceremony 2012

Photos from the Medical Advertising Hall of Fame Awards ceremony
 
Popular Topics
Acquisition Adherence App Celebrity Clinical Trial Co-Marketing Conflict Of Interest Diabetes Diagnostics Digital Direct To Consumer (DTC) Disease Awareness Downsize Education & Awareness FDA Government Guidance Health Plans HMOs Hospitals Insurers Law Marketing Research Mobile Sales Force